IL323559A - Meningococcal protein-based vaccines and methods for their preparation - Google Patents

Meningococcal protein-based vaccines and methods for their preparation

Info

Publication number
IL323559A
IL323559A IL323559A IL32355925A IL323559A IL 323559 A IL323559 A IL 323559A IL 323559 A IL323559 A IL 323559A IL 32355925 A IL32355925 A IL 32355925A IL 323559 A IL323559 A IL 323559A
Authority
IL
Israel
Prior art keywords
manufacturing
methods
vaccine formulations
protein based
based vaccine
Prior art date
Application number
IL323559A
Other languages
English (en)
Hebrew (he)
Inventor
Shankar Pisal Sambhaji
Sarma Annamraju Dattatreya
Mhalasakant Dhere Rajeev
Original Assignee
Serum Institute Of India Pvt Ltd
Shankar Pisal Sambhaji
Sarma Annamraju Dattatreya
Mhalasakant Dhere Rajeev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serum Institute Of India Pvt Ltd, Shankar Pisal Sambhaji, Sarma Annamraju Dattatreya, Mhalasakant Dhere Rajeev filed Critical Serum Institute Of India Pvt Ltd
Publication of IL323559A publication Critical patent/IL323559A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL323559A 2023-03-24 2025-09-25 Meningococcal protein-based vaccines and methods for their preparation IL323559A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202321021121A IN202321021121A (enExample) 2023-03-24 2023-03-24
PCT/IN2024/050300 WO2024201502A1 (en) 2023-03-24 2024-03-22 Meningococcal protein based vaccine formulations and methods for manufacturing thereof

Publications (1)

Publication Number Publication Date
IL323559A true IL323559A (en) 2025-11-01

Family

ID=92903953

Family Applications (1)

Application Number Title Priority Date Filing Date
IL323559A IL323559A (en) 2023-03-24 2025-09-25 Meningococcal protein-based vaccines and methods for their preparation

Country Status (9)

Country Link
KR (1) KR20250166279A (enExample)
CN (1) CN121038809A (enExample)
AR (1) AR132199A1 (enExample)
AU (1) AU2024249503A1 (enExample)
IL (1) IL323559A (enExample)
IN (1) IN202321021121A (enExample)
MX (1) MX2025011286A (enExample)
TW (1) TW202444740A (enExample)
WO (1) WO2024201502A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119925588B (zh) * 2025-04-08 2025-07-01 北京华诺泰生物医药科技有限公司 基于gE/pORF7双抗原纳米晶与智能相变佐剂的重组带状疱疹疫苗
CN120227449A (zh) * 2025-05-21 2025-07-01 苏州聚微生物科技有限公司 B群脑膜炎球菌疫苗组合物及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012004275A2 (pt) * 2009-08-27 2016-11-16 Novartis Ag polipeptídios híbridos incluindo sequências meningocócicas de fhbp
WO2014145578A1 (en) * 2013-03-15 2014-09-18 The Children's Hospital Of Philadelphia Scalable manufacturing process to produce recombinant lentiviral vectors in serum-free suspension cell culture system
GB201614687D0 (en) * 2016-08-31 2016-10-12 Univ Oxford Innovation Ltd fHbp scaffold
CN110804102B (zh) * 2019-11-08 2021-07-20 苏州微超生物科技有限公司 B群脑膜炎球菌疫苗及其制备方法与应用

Also Published As

Publication number Publication date
CN121038809A (zh) 2025-11-28
AU2024249503A1 (en) 2025-10-16
KR20250166279A (ko) 2025-11-27
TW202444740A (zh) 2024-11-16
WO2024201502A1 (en) 2024-10-03
AR132199A1 (es) 2025-06-04
MX2025011286A (es) 2025-11-03
IN202321021121A (enExample) 2024-04-19

Similar Documents

Publication Publication Date Title
IL323559A (en) Meningococcal protein-based vaccines and methods for their preparation
EP4112648A4 (en) PROTEIN AND VACCINE AGAINST SARS-COV-2 INFECTION
EP4171626A4 (en) Stabilized coronavirus spike (S) protein immunogens and related vaccines
IN2014DN08830A (enExample)
EP4317177A4 (en) Trimeric S-RBD Protein Vaccine Against the Novel Coronavirus, its Preparation Method and Use
WO2006081007A3 (en) Use of flagellin in tumor immunotherapy
UA114286C2 (uk) Спосіб лікування staphylococcus aureus
WO2008054535A3 (en) Novel influenza m2 vaccines
EP3261667A4 (en) A vaccine composition comprising an immunogenic protein and combination adjuvants for use in eliciting antigen-specific t-cell responses
EP4272755A4 (en) COMBINED VACCINE FOR THE PREVENTION OF HAND, FOOT AND MOUTH DISEASES, PRODUCTION METHOD THEREOF AND USE THEREOF
EP4247401A4 (en) COMPOSITIONS AND METHODS FOR OPTIMIZED PEPTIDE VACCINES
EP1814393A4 (en) TOLEROGENIC VACCINATE AND METHOD
EP4098260A4 (en) ORAL PREPARATION OF EOMEPRAZOLE AND METHOD FOR PRODUCTION THEREOF
SG11202110623PA (en) Liposomal formulations, and methods of using and preparing thereof
ZA202203368B (en) Immunogenic compositions against enteric diseases and methods for its preparation thereof
EP4304639A4 (en) VACCINE METHOD AND COMPOSITION FOR BACTERIAL DISEASES IN INVERTEBRATES
DE60126490D1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
SG11202108896UA (en) Vaccine adjuvants and formulations
EP3784250A4 (en) METHOD OF ENHANCEMENT OF THE IMMUNOGENICITY OF WEAKLY IMMUNOGENIC ANTIGEN-SPECIFIC VACCINES USING YEAST ORAL BETA-GLUCANS
WO2004098636A8 (en) Vaccinating against infectious diseases using proteosomes
HK40100731A (zh) 用於优化的肽疫苗的组合物和方法
PL449432A1 (pl) Kompozycja szczepionki do zastosowania w profilaktyce chorób zakaźnych
CA3290028A1 (en) Compositions and methods for therapeutic or vaccine delivery
AU2020902546A0 (en) Vaccination methods and compositions
HK40117521B (zh) 一种脊髓灰质炎疫苗及其制备方法